Phase Analysis and Obstructive CAD on Rubidium PET
NCT01840696
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PI leaving facility
Conditions
Coronary Artery Disease
Interventions
DRUG:
Regadenoson
Sponsor
Emory University